Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Kenya Prior Treatment Outcome Code System

Active as of 2026-06-04

Raw json | Download

{
  "resourceType" : "CodeSystem",
  "id" : "prior-treatment-outcome-cs",
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem prior-treatment-outcome-cs</b></p><a name=\"prior-treatment-outcome-cs\"> </a><a name=\"hcprior-treatment-outcome-cs\"> </a><p>This case-sensitive code system <code>https://nshr-uat.sha.go.ke/fhir/CodeSystem/prior-treatment-outcome-cs</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">COMPLETE-RESPONSE<a name=\"prior-treatment-outcome-cs-COMPLETE-RESPONSE\"> </a></td><td>Complete Response</td><td>No evidence of disease following treatment.</td></tr><tr><td style=\"white-space:nowrap\">PARTIAL-RESPONSE<a name=\"prior-treatment-outcome-cs-PARTIAL-RESPONSE\"> </a></td><td>Partial Response</td><td>Significant tumour reduction but residual disease remains.</td></tr><tr><td style=\"white-space:nowrap\">STABLE-DISEASE<a name=\"prior-treatment-outcome-cs-STABLE-DISEASE\"> </a></td><td>Stable Disease</td><td>No significant change in tumour size.</td></tr><tr><td style=\"white-space:nowrap\">PROGRESSIVE-DISEASE<a name=\"prior-treatment-outcome-cs-PROGRESSIVE-DISEASE\"> </a></td><td>Progressive Disease</td><td>Tumour growth or spread during or after treatment.</td></tr><tr><td style=\"white-space:nowrap\">NOT-EVALUABLE<a name=\"prior-treatment-outcome-cs-NOT-EVALUABLE\"> </a></td><td>Not Evaluable</td><td>Response could not be assessed.</td></tr><tr><td style=\"white-space:nowrap\">TOXICITY-WITHDRAWAL<a name=\"prior-treatment-outcome-cs-TOXICITY-WITHDRAWAL\"> </a></td><td>Withdrawn — Toxicity</td><td>Treatment stopped due to unacceptable side effects.</td></tr><tr><td style=\"white-space:nowrap\">PATIENT-WITHDRAWAL<a name=\"prior-treatment-outcome-cs-PATIENT-WITHDRAWAL\"> </a></td><td>Withdrawn — Patient</td><td>Patient declined to continue treatment.</td></tr><tr><td style=\"white-space:nowrap\">ONGOING<a name=\"prior-treatment-outcome-cs-ONGOING\"> </a></td><td>Ongoing</td><td>Treatment is still in progress; outcome not yet determined.</td></tr></table></div>"
  },
  "url" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/prior-treatment-outcome-cs",
  "version" : "0.1.0",
  "name" : "PriorTreatmentOutcomeCS",
  "title" : "Kenya Prior Treatment Outcome Code System",
  "status" : "active",
  "experimental" : false,
  "date" : "2026-06-04T14:49:30+00:00",
  "publisher" : "Digital Health Agency (DHA), Kenya",
  "contact" : [
    {
      "name" : "Digital Health Agency (DHA), Kenya",
      "telecom" : [
        {
          "system" : "url",
          "value" : "https://dha.go.ke"
        },
        {
          "system" : "email",
          "value" : "info@dha.go.ke"
        }
      ]
    },
    {
      "name" : "Digital Health Agency Kenya – FHIR Team",
      "telecom" : [
        {
          "system" : "email",
          "value" : "info@dha.go.ke",
          "use" : "work"
        },
        {
          "system" : "url",
          "value" : "https://dha.go.ke",
          "use" : "work"
        }
      ]
    }
  ],
  "description" : "Codes representing the outcome of a prior oncology treatment course.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "KE",
          "display" : "Kenya"
        }
      ]
    }
  ],
  "caseSensitive" : true,
  "content" : "complete",
  "count" : 8,
  "concept" : [
    {
      "code" : "COMPLETE-RESPONSE",
      "display" : "Complete Response",
      "definition" : "No evidence of disease following treatment."
    },
    {
      "code" : "PARTIAL-RESPONSE",
      "display" : "Partial Response",
      "definition" : "Significant tumour reduction but residual disease remains."
    },
    {
      "code" : "STABLE-DISEASE",
      "display" : "Stable Disease",
      "definition" : "No significant change in tumour size."
    },
    {
      "code" : "PROGRESSIVE-DISEASE",
      "display" : "Progressive Disease",
      "definition" : "Tumour growth or spread during or after treatment."
    },
    {
      "code" : "NOT-EVALUABLE",
      "display" : "Not Evaluable",
      "definition" : "Response could not be assessed."
    },
    {
      "code" : "TOXICITY-WITHDRAWAL",
      "display" : "Withdrawn — Toxicity",
      "definition" : "Treatment stopped due to unacceptable side effects."
    },
    {
      "code" : "PATIENT-WITHDRAWAL",
      "display" : "Withdrawn — Patient",
      "definition" : "Patient declined to continue treatment."
    },
    {
      "code" : "ONGOING",
      "display" : "Ongoing",
      "definition" : "Treatment is still in progress; outcome not yet determined."
    }
  ]
}